Related Experiment Video
Updated: Aug 1, 2026
08:32
Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
Published on: December 4, 2010
Cardiac allograft vasculopathy--a changing perspective.
1Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02215, USA.
Zeitschrift Fur Kardiologie
|January 11, 2001
Summary
Cardiac allograft vasculopathy (CAV) is a complex condition involving multiple factors. Future therapies aim to modify both the donor organ and the recipient
Area of Science:
- Cardiology
- Immunology
- Transplantation Science
Background:
- Cardiac allograft vasculopathy (CAV) is a significant long-term complication after heart transplantation.
- It is characterized by diffuse intimal thickening and graft dysfunction.
Purpose of the Study:
- To elucidate the multifactorial nature of Cardiac allograft vasculopathy (CAV).
- To identify key therapeutic targets for preventing and treating CAV.
Main Methods:
- Review of recent clinical and basic studies on CAV.
- Analysis of contributing factors including fibrosis, arteritis, and atheroma.
Main Results:
- CAV is regulated by interacting forces at different stages of the disease process.
- Three primary forms of vasculopathy—fibrosis, arteritis, and atheroma—contribute to graft vascular disease.
Conclusions:
- Current CAV therapies must address both alloantigen-dependent and independent factors.
- Future strategies should involve donor manipulation (reducing antigenicity/ischemia) and recipient manipulation (donor-specific immune response modulation).
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...